Please Wait.....
Report
Alzheimer's Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Report I 2023-06-14 I 144 Pages I IMARC Group
The global alzheimer's drugs market size reached US$ 7.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.11% during 2023-2028.
Alzheimer's is a disease characterized by the degeneration of nerve cells in several areas of the brain. It causes loss of cognitive function, such as memory, language, thinking and behavior. The common symptoms of Alzheimer's include depression, memory impairment, loss of inhibitions, and problems with thinking and reasoning. It is usually diagnosed by performing physical exams, blood tests, brain imaging, and mental status and neuropsychological testing. According to the results, doctors prescribe different medications to alleviate symptoms. Alzheimer's drugs influence the functions of neurotransmitters, the chemicals involved in carrying messages between nerve cells in the brain.
Alzheimer's Drugs Market Trends:
Diabetes, obesity, heart diseases and high blood pressure (BP), in confluence with sedentary lifestyles, unhealthy dietary patterns and smoking, are some of the factors known to increase the chances of developing Alzheimer's disease. An increase in the prevalence of these ailments and lifestyle choices among the masses, coupled with the rising geriatric population, represents one of the key factors driving the market growth. Furthermore, the leading pharmaceutical companies are focusing on the development of drugs that prevent the disease and provide long-lasting improvements in cognitive functions. The market growth is further supported by the expansion of telehealth services and the growing traction of online pharmacies. These platforms have enabled disease diagnosis and drug delivery in remote regions. Apart from this, various Alzheimer's drugs are presently under late-stage clinical trials, including Aducanumab, Solanezumab and Insulin.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global alzheimer's drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug class and distribution channel.
Breakup by Drug Class:
Donepezil
Galantamine
Rivastigmine
Memantine
Others
Breakup by Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Stores
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbvie Inc., AstraZeneca PLC, Biogen Inc., Daiichi Sankyo Company Limited, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Eli Lilly and Company, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, Ono Pharmaceutical Co. Ltd., Pfizer Inc and Teva Pharmaceutical Industries Limited.
Key Questions Answered in This Report:
How has the global alzheimer's drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global alzheimer's drugs market?
What are the key regional markets?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global alzheimer's drugs market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Alzheimer's Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Class
6.1 Donepezil
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Galantamine
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Rivastigmine
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Memantine
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Distribution Channel
7.1 Hospital Pharmacy
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Retail Pharmacy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Online Stores
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbvie Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 AstraZeneca PLC
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Biogen Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Daiichi Sankyo Company Limited
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Eisai Co. Ltd.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Eli Lilly and Company
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 H. Lundbeck A/S
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 F. Hoffmann-La Roche AG
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 SWOT Analysis
13.3.9 Merck & Co. Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Novartis AG
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Ono Pharmaceutical Co. Ltd.
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis
13.3.12 Pfizer Inc.
13.3.12.1 Company Overview
13.3.12.2 Product Portfolio
13.3.12.3 Financials
13.3.12.4 SWOT Analysis
13.3.13 Teva Pharmaceutical Industries Limited
13.3.13.1 Company Overview
13.3.13.2 Product Portfolio
13.3.13.3 Financials
13.3.13.4 SWOT Analysis
Figure 1: Global: Alzheimer's Drugs Market: Major Drivers and Challenges
Figure 2: Global: Alzheimer's Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Alzheimer's Drugs Market: Breakup by Drug Class (in %), 2022
Figure 4: Global: Alzheimer's Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 5: Global: Alzheimer's Drugs Market: Breakup by Region (in %), 2022
Figure 6: Global: Alzheimer's Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 7: Global: Alzheimer's Drugs (Donepezil) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Alzheimer's Drugs (Donepezil) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Alzheimer's Drugs (Galantamine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Alzheimer's Drugs (Galantamine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Alzheimer's Drugs (Rivastigmine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Alzheimer's Drugs (Rivastigmine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Alzheimer's Drugs (Memantine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Alzheimer's Drugs (Memantine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Alzheimer's Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Alzheimer's Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Alzheimer's Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Alzheimer's Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Alzheimer's Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Alzheimer's Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Alzheimer's Drugs (Online Stores) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Alzheimer's Drugs (Online Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Alzheimer's Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Alzheimer's Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: North America: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: North America: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: United States: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: United States: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Canada: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Canada: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Asia Pacific: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Asia Pacific: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: China: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: China: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Japan: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Japan: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: India: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: India: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: South Korea: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: South Korea: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Australia: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Australia: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Indonesia: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Indonesia: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Others: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Others: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Europe: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Europe: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Germany: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Germany: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: France: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: France: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: United Kingdom: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: United Kingdom: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Italy: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Italy: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Spain: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Spain: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Russia: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Russia: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Others: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Others: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Latin America: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Latin America: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Brazil: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Brazil: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Mexico: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Mexico: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Others: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Others: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Middle East and Africa: Alzheimer's Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Middle East and Africa: Alzheimer's Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Global: Alzheimer's Drugs Industry: SWOT Analysis
Figure 74: Global: Alzheimer's Drugs Industry: Value Chain Analysis
Figure 75: Global: Alzheimer's Drugs Industry: Porter's Five Forces Analysis
Table 1: Global: Alzheimer's Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Alzheimer's Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
Table 3: Global: Alzheimer's Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 4: Global: Alzheimer's Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: Alzheimer's Drugs Market: Competitive Structure
Table 6: Global: Alzheimer's Drugs Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security